Research article Special Issues

Modeling different infectious phases of hepatitis B with generalized saturated incidence: An analysis and control


  • Hepatitis B is one of the global health issues caused by the hepatitis B virus (HBV), producing 1.1 million deaths yearly. The acute and chronic phases of HBV are significant because worldwide, approximately 250 million people are infected by chronic hepatitis B. The chronic stage is a long-term, persistent infection that can cause liver damage and increase the risk of liver cancer. In the case of multiple phases of infection, a generalized saturated incidence rate model is more reasonable than a simply saturated incidence because it captures the complex dynamics of the different infection phases. In contrast, a simple saturated incidence rate model assumes a fixed shape for the incidence rate curve, which may not accurately reflect the dynamics of multiple infection phases. Considering HBV and its various phases, we constructed a model to present the dynamics and control strategies using the generalized saturated incidence. First, we proved that the model is well-posed. We then found the reproduction quantity and model equilibria to discuss the time dynamics of the model and investigate the conditions for stabilities. We also examined a control mechanism by introducing various controls to the model with the aim to increase the population of those recovered and minimize the infected people. We performed numerical experiments to check the biological significance and control implementation.

    Citation: Tahir Khan, Fathalla A. Rihan, Muhammad Ibrahim, Shuo Li, Atif M. Alamri, Salman A. AlQahtani. Modeling different infectious phases of hepatitis B with generalized saturated incidence: An analysis and control[J]. Mathematical Biosciences and Engineering, 2024, 21(4): 5207-5226. doi: 10.3934/mbe.2024230

    Related Papers:

    [1] Jiying Ma, Shasha Ma . Dynamics of a stochastic hepatitis B virus transmission model with media coverage and a case study of China. Mathematical Biosciences and Engineering, 2023, 20(2): 3070-3098. doi: 10.3934/mbe.2023145
    [2] Tingting Xue, Long Zhang, Xiaolin Fan . Dynamic modeling and analysis of Hepatitis B epidemic with general incidence. Mathematical Biosciences and Engineering, 2023, 20(6): 10883-10908. doi: 10.3934/mbe.2023483
    [3] Yoichi Enatsu, Yukihiko Nakata . Stability and bifurcation analysis of epidemic models with saturated incidence rates: An application to a nonmonotone incidence rate. Mathematical Biosciences and Engineering, 2014, 11(4): 785-805. doi: 10.3934/mbe.2014.11.785
    [4] Xichao Duan, Sanling Yuan, Kaifa Wang . Dynamics of a diffusive age-structured HBV model with saturating incidence. Mathematical Biosciences and Engineering, 2016, 13(5): 935-968. doi: 10.3934/mbe.2016024
    [5] Tailei Zhang, Hui Li, Na Xie, Wenhui Fu, Kai Wang, Xiongjie Ding . Mathematical analysis and simulation of a Hepatitis B model with time delay: A case study for Xinjiang, China. Mathematical Biosciences and Engineering, 2020, 17(2): 1757-1775. doi: 10.3934/mbe.2020092
    [6] Maysaa Al Qurashi, Saima Rashid, Fahd Jarad . A computational study of a stochastic fractal-fractional hepatitis B virus infection incorporating delayed immune reactions via the exponential decay. Mathematical Biosciences and Engineering, 2022, 19(12): 12950-12980. doi: 10.3934/mbe.2022605
    [7] Dong-Me Li, Bing Chai, Qi Wang . A model of hepatitis B virus with random interference infection rate. Mathematical Biosciences and Engineering, 2021, 18(6): 8257-8297. doi: 10.3934/mbe.2021410
    [8] Sarah Kadelka, Stanca M Ciupe . Mathematical investigation of HBeAg seroclearance. Mathematical Biosciences and Engineering, 2019, 16(6): 7616-7658. doi: 10.3934/mbe.2019382
    [9] Kangbo Bao, Qimin Zhang, Xining Li . A model of HBV infection with intervention strategies: dynamics analysis and numerical simulations. Mathematical Biosciences and Engineering, 2019, 16(4): 2562-2586. doi: 10.3934/mbe.2019129
    [10] Junyoung Jang, Kihoon Jang, Hee-Dae Kwon, Jeehyun Lee . Feedback control of an HBV model based on ensemble kalman filter and differential evolution. Mathematical Biosciences and Engineering, 2018, 15(3): 667-691. doi: 10.3934/mbe.2018030
  • Hepatitis B is one of the global health issues caused by the hepatitis B virus (HBV), producing 1.1 million deaths yearly. The acute and chronic phases of HBV are significant because worldwide, approximately 250 million people are infected by chronic hepatitis B. The chronic stage is a long-term, persistent infection that can cause liver damage and increase the risk of liver cancer. In the case of multiple phases of infection, a generalized saturated incidence rate model is more reasonable than a simply saturated incidence because it captures the complex dynamics of the different infection phases. In contrast, a simple saturated incidence rate model assumes a fixed shape for the incidence rate curve, which may not accurately reflect the dynamics of multiple infection phases. Considering HBV and its various phases, we constructed a model to present the dynamics and control strategies using the generalized saturated incidence. First, we proved that the model is well-posed. We then found the reproduction quantity and model equilibria to discuss the time dynamics of the model and investigate the conditions for stabilities. We also examined a control mechanism by introducing various controls to the model with the aim to increase the population of those recovered and minimize the infected people. We performed numerical experiments to check the biological significance and control implementation.



    The liver is a vital organ in a living body. Several diseases caused due to the consequences of liver infections. Hepatitis B is the liver inflammation produced by hepatitis B virus (HBV) [1]. Hepatitis B damages the liver cells and, as a result, produces liver inflammation [2,3]. Hepatitis B is a multi-infection disease causing acute and chronic hepatitis infection, which leads to a long-term existence of infection and risk of liver cancer. The initial stage is up to six months of the infection known as the acute HB-infection in which, usually, the immune system is capable of surviving the infection, but there may also be a chance for the infection to become more severe and lead to chronic hepatitis B infection [4]. More than two hundreds and fifty million individuals have chronic hepatitis B worldwide as per WHO information. Moreover, every year the infection of hepatitis B causes approximately 1 million deaths worldwide due to cirrhosis of liver and liver cancer. Particularly in the Western Pacific region and Africa, the burden of hepatitis B infection is high because an estimated 6.2% and 6.1% of the population, respectively, live with chronic hepatitis B infection. Nevertheless, the infection is not limited to the Western Pacific region and Africa only, but is a global health problem, and the infection rates are also significant in other ares such as Southeast Asia and the Eastern Mediterranean.

    HBV transmits in various ways, but the critical transmission routes are vaginal secretions, transfusion of semen as well as blood, sharing razors without care, sexual interaction, and drug equipment contaminated with infected blood of the virus of hepatitis B. Another primary source of this virus is vertical or parental transmission, i.e., the infected mother can transmit it to their baby at birth. Children of ages 1–6 years have a 90% chance of getting the infection of hepatitis B after exposure to the virus [5]. However, the virus cannot transmit due to casual contact like drinking water, eating, kissing, and hugging. Similarly, the virus cannot be transmitted through general gatherings like in universities, schools, colleges, or other places [6,7]. Symptoms of this virus may include nausea, fatigue, vomiting, muscle and joint aches, yellow skin and dark urine, diarrhea, easy bruising, tiredness, etc.

    Modeling the epidemiology of infectious disease is one of the important and emerging areas of applied mathematics as well as applied science that will be used to forecast the long dynamical behavior of various epidemics [8,9,10,11,12,13,14,15]. Several biologists, mathematicians, and researchers used the concept of mathematical modeling to investigate the dynamics of contagious diseases. Daniel Bernoulli was the first one in mathematical epidemiology to present a model describing smallpox dynamics in 1766 [16]. Kermack and Mckandrik presented the susceptible-infected-recovered (SIR) epidemiological model to represent the dynamics of infectious disease among three groups of the population [17]. In order to control the spread of HIV, a model with protection awareness is investigated by Zhai et al. [18]. As a global issue, numerous models are investigated to study the dynamics of HB [19,20,21]. Furthermore, a control strategy has been investigated by Medley et al. [22] to eliminate the contagious viral infection of HBV. Likewise, an age-structured model reported for the dynamics of HBV in China by Zhao et al. [23]. Similarly, the temporal dynamics of HBV with controls analysis have been investigated in [24,25]. Motivated by the work reported in [25], we study the dynamics of hepatitis B under the effect of various infectious phases and generalized incidence rate.

    The disease incidence parameter is a critical term in epidemiological models that help researchers and policymakers correctly understand the burden and spread of diseases. Notably, it can measure disease frequency, helps with disease surveillance and assessment of disease prevention, enables resource allocation, evaluates the effectiveness of interventions, etc. The simple incidence rate is bilinear, βSI, which has been frequently exercised in numerous epidemiological models [26,27,28], where β is the contact rate, S is the amount of susceptible, and I is the amount of infected. The concept of saturated incidence rate, βIS1+γI has been introduced by Capasso et al. [29], where β is the disease transmission ratio, while γ is the parameter which captures the effect of behavioral changes on the spread of the disease. Afterward, many authors have been used the concept of saturated incidence rate while formulating epidemic models (see, for instance, [30,31]). Usually, when a disease outbreak occurs, individuals may change their behavior in various ways, such as practicing better hygiene, avoiding crowded places, or wearing masks, which ultimately reduce the transmission of the disease and slow its spread. The parameter 11+γI measures the degree to which susceptible individuals change their behavior in response to the outbreak. Overall, the saturated incidence rate is more beneficial for studying the spread of infections and investigating behavioral changes' impact on disease transmission [32]. However, the saturated incidence rate may not work well for a disease with multiple infection phases because this formula assumes only a single infected group of individuals, which may not be accurate for infection with various phases or stages. We will try to fill this gap by introducing a more general form of saturated incidence rate as β{I1+I2+,In}S1+γ{I1+I2+,In}, where I1,I2,,In represent the different infection phases of the disease.

    In this work, we construct an epidemiological model with a rate of generalized incidence to represent the dynamics of multi-infection disease of HBV. We develop the model according to the multi-infection phases of HB and divide the whole population into five subgroups of the compartmental population. We then discuss boundedness and positivity to show that the proposed epidemiological model is a well-posed dynamical system. We also find the reproductive quantity and model equilibria to investigate the qualitative analysis of the epidemic model. We discuss the local dynamical properties of the model with the aid of the linear stability approach, while to discuss the global properties of the problem, we use the Lyapunov theory. Based on the dynamics of the model, we then define a suitable control mechanism to control the infection of HBV transmission with the aid of optimal control theory. Three control measures, precautionary control measure, treatment of infected individuals, and vaccination control measure, are suggested to reduce the infected individuals with multi-infection phases and maximize the non-infected individuals. Finally, to show the validation of the analytical work and the effect of the control measures, we present the detailed numerical simulation using the well-known numerical procedure of the Runge-Kutta method.

    The article structure is as follows: The detailed model formulation and its well-posedness are discussed in the Section 2, then in Section 3, we discuss the qualitative analysis of the model to derive the stability conditions. We then develop the control mechanism to eradicate the infection by taking the extended version of the model in Section 4. The detailed existence analysis and the charecterization of the optimal control problem are given in Section 5. Next, we present the model simulation to verify our theoretical analysis and show the effect of control measures implemented in Section 6. We give a conclusion in Section 7.

    We develop the model to investigate the transmission dynamics of HBV. Since obviously hepatitis B is a multi-infection phase disease, we use the generalized saturated incidence β{I1+I2+,In}S1+γ{I1+I2+,In}, while formulating the proposed model. Keeping in view the complex nature of the disease, we classify the various classes of population into sub-groups of susceptible, acute, chronic, hospitalized and recovered individuals denoted by S(t), Ia(t), Ic(t), H(t), and R(t), respectively. Since, Ia(t) and H(t) respectively represent the acute and hospitalized individuals, and usually do not transmit the disease to others, the disease transmission co-efficient for Ia(t) and H(t) are assumed to be zero. So, the generalized saturated incidence rate in this case looks like τS(t)Ic(t)1+θ1Np(t). In addition, because of the population dynamics, we assume that all the model states variables and parameters are non-negative values. Moreover, moving of the infected individuals (acute & chronic) leads to the hospitalized, while two types of recoveries are assumed as per HBV characteristics, natural for acute and due to treatment for the chronic portion of the population. We also assume the recovery is due to hospitalization. Natural death occurs in every population group, so the outflow of natural death is assumed in all groups of the compartmental population. In contrast, disease-induced death occurs due to the chronic infection. In addition, it is clear that vaccines for hepatitis B are available and effective, therefore we assume that the vaccinated individuals of the susceptible enter the recovered epidemiological group of the model. Thus, we present the model as follows:

    {dS(t)dt=ΠτS(t)Ic(t)1+θ1Np(t){α0+ν}S(t),dIa(t)dt=τS(t)Ic(t)1+θ1Np(t){α0+θ2+κ1+τ1}Ia(t),dIc(t)dt=θ2Ia(t){α0+κ2+ρ1+τ2}Ic(t),dH(t)dt=τ1Ia(t)+τ2Ic(t){α0+ρ2+τ3}H(t),dR(t)dt=κ2Ic(t)+νS(t)+τ3H(t)α0R(t)+κ1Ia(t), (2.1)

    with the initial compartmental population

    S(0)>0,Ia(0),Ic(0),H(0)0,R(0)>0. (2.2)

    In Eq (2.1), Π is the birth rate, τ is the transmission coefficient of HBV, while θ2 is the parameter that describes the rate at which acutely infected individuals enter the chronic group. ν is assumed to be the vaccination rate. The parameter τ1 is the rate at which the acutely infected population enters the hospitalized group of individuals, and ρ1 represents the death rate produced from the HBV infection. The individuals who move from the chronic to the hospitalized group are symbolized by τ2 while ρ2 is also the death caused by the HBV infection in a hospitalized group. Moreover, to define the recovery of hospitalized individuals, we demonstrate it by τ3, and the natural death of all groups of the compartmental population is denoted by α0. In addition, Np(t) is the sum of all infected population, i.e., Np(t)=Ia(t)+Ic(t)+H(t).

    In this subsection, we will provide the validity of the proposed model against regional data taken from local hospitals of district Swat, Khyber Pakhtunkhwa, Pakistan, as shown by Figure 1(a). Since, according to 2017, the total population of district Swat is 2.31 million and thus the demographic parameter is calculated as Π/α0=2,310,000, where α0=(1/67.7) is the average life span in Pakistan. In addition, the procedure of ordinary least square (OLS) will be applied to obtain the best fit and to minimize the error between the reported data and the proposed model solutions. For this purpose, we use the objective function is given by

    L=argminni=1(xiˆxi),

    where xi and ˆxi respectively represent the actual cumulative hepatitis B reported cases and the associated model solution, while n is the number of actual data points. Using the optimization algorithm, while updating the parameters values to derive better agreement with the real data and to minimize the error. The process is repeated until reaching the best model fit, as in Figure 1(b), which shows the validity of the model in the case of application to a real scenario.

    Figure 1.  The graphs represent the number of hepatitis B reported cases from 2016 to 2023 in district Swat, Khyber Pakhtunkhwa, Pakistan (1a) and the model fitting against reported data (1b).

    The proposed epidemiological model (2.1) represents the dynamics of compartmental populations; therefore, we need to check whether the state of the considered problem is non-negative for all t with the initial compartmental population given in Eq (2.2). We also investigate that the considered model is bounded. For this, we study the results as given below.

    Theorem 2.1. All the solutions (S(t),Ia(t),Ic(t),H(t),R(t)) of the model (2.1) with the initial compartmental sizes (2.2) remain non-negative and are uniformly bounded in the positively invariant region Ω for all non-negative t.

    Proof. The solution of the model (2.1), first equation, can be written as

    S(t)=exp{t0ψ(y)dy}S(0)+Πexp{t0ψ(y)dy}t0exp{y0ψ(x)dx}dy, (2.3)

    where ψ(t)={τIc(t)1+θ1Np(t)(α0+ν)}S(t). From the epidemiological model (2.1), second equation, we have

    dIa(t)dt{α0+θ2+κ1+τ1}Ia(t),

    which leads to

    Ia(t)Ia(0)exp{t0{α0+θ2+κ1+τ1}ds}0. (2.4)

    In a similar fashion, the third equation of the model takes the following form:

    dIc(t)dt{α0+κ2+ρ1+τ2}Ic(t).

    After that, integration gives

    Ic(t)Ic(0)exp{t0{α0+κ2+ρ1+τ2}ds}0. (2.5)

    By following the same steps, we may write the fourth and fifth equations of the model as

    dH(t)dt{α0+ρ2+τ3}H(t),dR(t)dtα0R(t),

    which implies that

    H(t)H(0)exp{t0{α0+ρ2+τ3}ds}0, (2.6)

    and

    R(t)R(0)exp{t0α0ds}0. (2.7)

    We observed from the above equations that the system (2.1) satisfying the conditions (2.2) remains non-negative for every t0.

    To proceed further, let N(t) demonstrate the size of whole population, then

    dN(t)dtΠα0N(t),

    which yields that

    0<N(t)Πα0{1eα0t}+N(0)eα0t. (2.8)

    From the Eq (2.8), we note that N(t) becomes less than or equal to Πα0 as time grows unboundedly. Thus it follows that the total population in the region {R5+{0}} is bounded by Πα0 with growing time (t), therefore, the solution trajectories of the model satisfying the initial conditions are bounded.

    Since the model state variables are non-negative and N(t)Πα0, it is implied that the proposed problems (2.1) and (2.2) is well-posed. Further, we assume that N(0)Πα0, then from Eq (2.8), we conclude that N(t)Πα0, and thus every solution of the proposed epidemic problem with initial conditions in R5+ remains in Ω as

    Ω={(S(t),Ia(t),Ic(t),H(t),R(t))R5+:N(t)Πα0}. (2.9)

    We discuss the dynamics of the proposed model by investigating the model equilibria. Clearly, the disease-free state (DFE) of the system (2.1) is represented by Edf and written as Edf=(S0,I0a,I0c,H0,R0)=(Πα0+ν,0,0,0,νΠα0(α0+ν)). Before calculating the hepatitis B endemic state, we find the reproductive parameter, denoted by R0, defined to be the threshold quantity (basic reproductive number), while demonstrating the average of newly infected caused by an infected after introducing them into a susceptible population. In the case of classical epidemiological models, when R0<1, the disease dies out. If R0>1, then it will be expected that the disease is spreading. We use the next-generation method to investigate this quantity as reported in [33,34]. Upon using the same methodology as adopted by [34], we assume that Y=(Ia,Ic,H)T. Then

    dYdt=(FV)Y,

    where

    V=(α0+θ2+κ1+τ100θ2α0+κ2+ρ1+τ20τ1τ2α0+ρ2+τ3),F=(0τS00000000),Y=(IaIcH).

    The reproductive number, R0 is defined to be the spectral radius of the matrix FV1, thus it is given by

    R0=θ2τΠψ1ψ2ψ3, (3.1)

    where ψ1=α0+ν, ψ2=α0+θ2+κ1+τ1, and ψ3=α0+κ2+ρ1+τ2. The reproductive number is a dimensionless rate representing the average of secondary hepatitis B cases produced whenever a hepatitis B-infected person is introduced into the susceptible population. Thus, it is clear that if R0<1 and the initial sizes of the population's compartments are in the hepatitis-free state, then the hepatitis B disease vanishes. For this, we prove the subsequent result.

    Theorem 3.1. If R0<1, then the epidemiological problem (2.1) is stable locally and globally at the hepatitis-free state, Edf=(Πα0+ν,0,0,0,νΠα0(α0+ν)), otherwise Edf is unstable and is a saddle point.

    Proof. We calculate the linearized matrix of the system (2.1) at hepatitis-free state (Edf) as

    J(Edf)=(ψ10τS0000ψ2τS0000θ2ψ3000τ1τ2ψ40vκ1κ2τ3α0).

    Calculating the eigenvalues of J(Edf) implies that three eigenvalues are negative, i.e., ψ1, ψ4 and α0 are negative. For the remaining two eigenvalues, we take a 2×2 matrix given as

    B=(ψ2τS0θ2ψ3).

    It is enough to show that the trace of B is B<0 and the determinant of B is B>0 for the Routh-Hurwitz criteria, thus whenever R0<1, then

    trace(B)=(ψ2+ψ3),

    and

    determinant(B)=ψ2ψ3(1R0),

    imply that the above criteria hold subject to the condition of R0<1. Clearly, trace(B)<0 and determinant(B)>0 when R0<1. However, in case of R0>1, the trace(B)<0 as well as determinant(B)<0, which implies that the eigenvalues of B have the alternative sign, i.e., positive as well as negative, so the Edf is an unstable equilibrium point.

    We calculate the global dynamics properties of the model (2.1) at Edf, and therefore define a Lyapunov function, such that

    φ(t)=λ1(SS0)+λ2Ia+λ3Ic, (3.2)

    where λi for i=1,2,3,4 are constants assumed to be positive. The derivative of the function (3.2) with the use of values from the model (2.1), leads to

    dφdt=λ1{ΠτSIc1+θ1Npψ1S}+λ2{τSIc1+θ1Npψ2Ia}+λ3{θ2Iaψ3Ic}. (3.3)

    By assuming the positive constants in such a way that λ1=λ2=ψ1 and λ3=τΠ in Eq (3.3), we get the following equation:

    dφdt=ψ1{ψ1S0ψ1S}ψ1ψ2Ia+τΠθ2Iaψ2Ic.

    Algebraic manipulation gives that

    dφdt=ψ21{SS0}ψ1ψ2{1τΠθ2ψ1ψ2}Iaψ2Ic,

    which implies that

    dφdt=ψ21{SS0}ψ1ψ2{1R0}Iaψ2Ic.

    Therefore, dφdt is negative, if R01. Moreover, dφdt=0, whenever S=S0,I0a=0,I0c=0,H0=0.

    Next, we examine the properties of the hepatitis B endemic state for the considered epidemic problem. To shorten our calculation, we assume that ψ4=α0+ρ2+τ3 and Eee=(Sσ,Iσa,Iσc,Hσ,Rσ) is the endemic state of the model, then

    Sσ={1+θ1Np}θ2τψ2ψ3,Iσa=ψ1{1+θ1Np}{R01}θ2τψ3,Iσc=1τψ1{1+θ1Np}{R01},Hσ=ψ1{1+θ1Np}τψ4{τ1θ2ψ2+τ2}{R01},Rσ=1α0[ψ1{1+θ1Np}τ{κ1τθ2ψ2+κ2+τ1τ3θ2ψ3ψ3+τ2τ3ψ4}{R01}+ν{1+θ1Np}ψ2ψ3θ2τ]. (3.4)

    To present the dynamics of the hepatitis B endemic state, we prove the result as given below.

    Theorem 3.2. The proposed problem (2.1) is stable at Eee=(Sσ,Iσa,Iσc,Hσ,Rσ), if R0>1.

    Proof. Calculating the Jacobian at the Eee of the proposed model, we may obtain

    J(Eee)=(θ2τΠNp(1+θ1Np)ψ2ψ20ψ2ψ3θ200θ2τΠNp(1+θ1Np)ψ2ψ3ψ2ψ2ψ3θ2000θ2ψ3000ττ2ψ40vκ1κ2τ3α0).

    It is clear from the above matrix that α0 and ψ4 are the two negative eigenvalues. To find the eignvalue's nature, we may define

    G=(θ2τΠNp(1+θ1N)pψ2ψ30ψ2ψ3θ2θ2τΠNp(1+θ1Np)ψ2ψ3ψ2ψ2ψ3θ20θ2ψ3).

    Calculating the characteristic polynomial of the above matrix G, we have

    f(y)=y3+k1y2+k2y+k3,

    where

    k1={α0+ν}+ψ2+ψ3+{α0+ν}{R01},k2={ψ1+ψ2}{α0+ν}+{ψ1+ψ2}{α0+ν}{R01},k3=ψ1ψ2{α0+ν}{R01}.

    All ki>0 for i = 1, 2, 3 and k1k2>k3, which ensure the criteria of Routh-Hurwitz because k1>0, k3>0 and k1k2>k3, whenever R0>1. Thus, f(y) has negative roots whenever R0>1, and so Eee is the stable state of the model that is under consideration.

    We now discuss the properties of global analysis of the proposed problem (2.1) at the hepatitis B endemic state. To investigate the global properties of the problem at the hepatitis B endemic state, we define the following function:

    ξ(t)=12{(SSσ)+(IaIσa)+(IcIσc)+(HHσ)}2. (3.5)

    The temporal derivative of Eq (3.5) with respect to t, and using model (2.1), gives

    dξdt={(SSσ)+(IaIσa)+(IcIσc)+(HHσ)}{Πψ1S          (α0+κ1)Ia(α0+κ2+ρ1)Ic(α0+ρ2+τ3)H}, (3.6)

    which implies that

    dξdt={(SSσ)+(IaIσa)+(IcIσc)+(HHσ)}{(α0+κ1)Iσa    +θ2Iσa+τ1Iσa+(α0+ν)Sσ(α0+ν)S(α0+κ1)Ia                                              (α0+κ2+ρ1)Ic(α0+ρ2+τ3)H},

    or equivalently we can write

    dξdt={(SSσ)+(IaIσa)+(IcIσc)+(HHσ)}{(α0+ν)(SSσ)+(α0+κ1)(IaIσa)+1τ(α0+ν)(1+θ1Np)(α0+κ2+ρ1)(R01)+(α0+κ2+ρ1)Ic+τ2τ(α0+ν)(1+θ1Np)(R01)+τ1θ2τ(α0+ν)(1+θ1Np)(α0+κ2+ρ1)(R01)+(α0+ρ2+τ3)H}.

    The re-arrangement with full simplification leads to the following assertion:

    dξdt={(SSσ)+(IaIσa)+(IcIσc)+(HHσ)}{(α0+ν)(SSσ)+(α0+κ1)(IaIσa)+(α0+κ2+ρ1)Ic+(α0+ρ2+τ3)H+1τ(α0+ν)(1+θ1Np){(α0+κ2+ρ1+τ2)+τ1θ2(α0+κ2+ρ1)}(R01)}.

    By simplifying and re-writing, we obtain

    dξdt={(SSσ)+(IaIσa)+(IcIσc)+(HHσ)}{(α0+ν)(SSσ)+(α0+κ1)(IaIσa)+(α0+κ2+ρ1)Ic+(α0+ρ2+τ3)H+1τθ2(α0+ν)(1+θ1Np){(θ2+τ1)(α0+κ2+ρ1)+θ2τ2}(R01)}.

    Hence, dξdt<0 for all S, Ia, Ic, H, R, and dξdt=0 at the endemic state, so the hepatitis B endemic state Eee is the positively invariant set only containing {(S,Ia,Ic,H,R):S=Sσ, Ia=Iσa,Ic=Iσc,H=Hσ,R=Rσ}, which implies that Eee is a stable state.

    Optimal control theory is a powerful mathematical technique through which we can develop control strategies to control different infectious diseases, i.e., hepatitis B virus. We make a control mechanism for the infection of hepatitis B with the objective to reduce the number of infective by taking into account the maximization of S(t) as well as R(t) populations while to minimizing Ia(t) and Ic(t). For this purpose, three control measures dependent over time will be used, i.e., ui(t), ut(t), and uv(t), which physically represent the preventive measures of hepatitis B, treatment of infected individuals, as well as vaccination, respectively. Clearly, there are five state variables, i.e., S(t), Ia(t), Ic(t), H(t), and R(t), therefore, we then assume the above three control measures to design the control problem as

    Y(ui,ut,uv)=L0{C1S(t)+C2(t)Ia(t)+C3Ic(t)+12(D1u2i(t)+D2u2t(t)+D3u2v(t))}dt, (4.1)

    subject to

    {dS(t)dt=ΠτS(t)Ic(t)1+θ1Np(t){1ui(t)}{α0+uv(t)}S(t),dIa(t)dt=τS(t)Ic(t)1+θ1Np(t){1ui(t)}{α0+θ2+κ1+τ1+ut(t)+uv(t)}Ia(t),dIc(t)dt=θ2Ia(t){α0+κ2+ρ1+τ2}Ic(t){uv(t)+ut(t)}Ic(t),dH(t)dt=κ1Ia(t)+τ2Ic(t){α0+ρ2+τ3}H(t){ut(t)+uv(t)}H(t),dR(t)dt=τ1Ia(t)+κ2Ic(t)+uv(t)S(t)α0R(t)+{ut(t)+uv(t)}{Ia(t)+Ic(t)}+τ3H(t)+{ut(t)+uv(t)}H(t), (4.2)

    with

    S(0)>0,Ia(0)0,Ic(0)0,H(0)0,R(0)>0. (4.3)

    In the earlier section, i.e., in Section (2.1), the description of parameters is discussed in detail, while in the objective functional (4.1), C1, C2, and C3 illustrate the weight constants for the proposed control strategies. The weight constants, D1, D2, and D3 are the constants relating to the control measures of preventive measures, treatment of infected individuals, and vaccination, respectively. Moreover, the terms 12D1u2i(t), 12D2u2t(t), and 12D3u2v(t) demonstrate the associated cost with the control measures. Thus, we wish to find the control measures that minimize the objective function, such that

    Y(uσi,uσt,uσv)=min{Y(ui,ut,uv),ui,ut,uvM}, (4.4)

    subject to the system (4.2). The control set is described by

    M={(ui,ut,uv):ui(t)is Lebesgue measurable on[0,1],0ui(t)1,0ut(t)1and0uv(t)1}.

    We discuss the existence analysis, and therefore assume the control system as stated by Eq (4.2) with initial conditions. It is very clear that for Lebesgue measurable and bounded control measures, initial conditions (positive) and bounded solutions (positive) to the proposed system exist. Moreover, we go back to the control problem as stated by Eq (4.2), as well as Eq (4.4), to figure out the optimal solution. We define the Lagrangian first and then the Hamiltonian for the said purposes, i.e., for the optimal problem (4.2) and (4.4). Consequently, the Lagrangian takes the form

    Lopt(S,Ia,Ic,ui,ut,uv)=C1S(t)+C2Ia(t)+C3Ic(t)+12{D1u2i(t)+D2u2t(t)+D3u2v(t)}.

    In addition, for the minimal value of Lopt, we define the Hamiltonian, such that

    Hopt=Lopt(S,Ia,Ic,ui,ut,uv)+χ1dS(t)dt+χ2dIadt+χ3dIcdt+χ4dHdt+χ5dRdt. (5.1)

    Thus, for the existence of such controls, first we prove the existence; therefore, regarding the existence, we illustrate the following result.

    Theorem 5.1. There exists an optimal control uσopt=(uσi,uσt,uσv)M, such that

    Y(uσi,uσt,uσv)=minY(ui,ut,uv), (5.2)

    subject to the control system as reported in Eq (4.2).

    Proof. Following the same methodology as used in [35,36], we explore the existence analysis of the optimal control functions. Clearly, the state, as well as control, are non-negative values. So, the necessary condition of convexity for the objective functional (4.1) over ui(t), ut(t), and uv(t) holds. The control variable set ui,ut,uvM is obviously closed as well as convex and so implies the optimal system's boundedness. This grants compactness. Also, the integrand C1S(t)+C2(t)Ia(t)+C3Ic(t)+12{D1u2i(t)+D2u2t(t)+D3u2v(t)} is convex over M.

    Now the optimal solution will be determined to the proposed control problem. For this, the Pontryagin Maximum Principle will be utilized. If

    Hpmp(t,y,u,χ)=f(t,y,u)+χ(t)g(t,y,u), (5.3)

    where y=(S(t),Ia(t),Ic(t),H(t),R(t)) and u=(ui,ut,uv), while f is the Lagrangian of the objective function (4.1) and g=(g1,g2,g3,g4,g5) represent the right-hand side of the first, second, third, fourth, and fifth equations of the control system (4.2). Thus, if (yσ,uσ) is an optimal solution, then a non-trivial vector χ(t) (a set of adjoint variables) exists, such that χ(t)=(χ1(t),χ2(t),,χ5(t)), satisfying

    dydt=Hpmp(t,yσ,uσ,χ)χ,0=Hpmp(t,yσ,uσ,χ)u,χ(t)=Hpmp(t,yσ,uσ,χ)y. (5.4)

    Moreover, the necessary condition will be applied to the Hamiltonian in terms of the following results.

    Theorem 5.2. Let Sσ, Iσa, Iσc, Hσ, and Rσ be the optimal solution with associated optimal control measures (uσi,uσt,uσv) for the problem (4.2)–(4.4), then the adjoint variables χ1(t), χ2(t), χ3(t), χ4(t), and χ5(t) exist and satisfy

    dχ1(t)dt=C1τIσc1+θ1Np{χ2(t)χ1(t)}{1uσi(t)}+{χ1(t)χ5(t)}uσv(t)+α0χ1(t),dχ2(t)dt=C2+{χ2(t)χ5(t)}{uσt(t)+uσv(t)}{χ3(t)χ2(t)}θ2{χ4(t)χ2(t)}τ1{χ5(t)χ2(t)}κ1+α0χ2(t),dχ3(t)dt=C3τS1+θ1Np{χ2(t)χ1(t)}{1uσi(t)}{χ5(t)χ3(t)}{uσt(t)+uσv(t)}+{χ3(t)χ4(t)}τ2+{χ3(t)χ5(t)}κ2+{α0+ρ1}χ3,dχ4(t)dt={χ4(t)χ5(t)}{uσt(t)+uσv(t)}+{χ4(t)χ5(t)}τ3+{α0+ρ2}χ4,dχ5(t)dt=α0χ5, (5.5)

    with boundary (transversality) conditions

    χi(M)=0,wherei=1,,5. (5.6)

    Further, the optimal control measures uσi(t), uσt(t), and uσv(t) are defined as

    uσi(t)=max{min{1D1(1+θ1Np)τSσIσc(χ2(t)χ1(t)),1},0},uσt(t)=max{min{1D2(χ2(t)χ5(t))Iσa+(χ3(t)χ5(t))Iσc+(χ4(t)χ5(t))Hσ,1},0},uσv(t)=max{min{1D3(χ1(t)χ5(t))Sσ(χ5(t)χ2(t))Iσa(χ5(t)χ3(t))Iσc(χ5(t)χ4(t))Hσ,1},0}.

    Proof. We use the Hamiltonian (5.3) for finding the adjoint system (5.5) as well as the transversality condition (5.6). We set S(t)=Sσ, Ia(t)=Iσa, Ic(t)=Iσc, H(t)=Hσ, and R(t)=Rσ, while the differentiation of Hpmp with respect to S(t), Ia(t), Ic(t), H(t), and R(t) leads to the system (5.5). Moreover, to get uσi, uσt, and uσv, Hpmp will be differentiated respectively with respect to ui, ut and uv, and then the solution of Hpmpui=0, Hpmput=0, and Hpmpuv=0, in the interior of control set with the application of optimality condition. In the end, the use of the control property M gives the optimal value of the control variables.

    We recall the formula uσ=(uσi,uσt,uσv) to characterize the optimal control problem, which consists of the state system with the initial sizes of compartmental populations, the adjoint system with terminal conditions and the optimal measures. We further use the iterative procedure to solve the proposed optimal control problem.

    We illustrate the numerical findings of the analytical results to demonstrate the feasibility of the derived results graphically. We solve the proposed problem via the Runge-Kutta method of the 4th order, along with various initial sizes of population and different sets of parameter values as given in the captions of the figures. Moreover, the time unit is taken to be 0–100. Moreover, the parameters values are taken in accordance with the theoretical results that have been carried out in Theorems 3.1 and 3.2, and are given at the captions of the figures. We generate the following graphs as shown in Figures 2 and 3, which are respectively illustrating the verification of analytical results around disease–free and endemic states. More specifically, Figure 2 represents the dynamics of the compartmental populations of the model around the hepatitis free state, while the disease endemic state dynamics are represented by Figure 3. In Figure 2, the graphs (a)–(e) respectively describe the dynamics of susceptible, acute, chronic, hospitalized, and recovered populations, which show that all other individuals vanish except susceptible and the recovered populations, whenever R0<1. However, if R0>1, the disease may reach the endemic state as shown in Figure 3, implies that the infected individuals will always persist and there is a need for interventions strategies to control the transmission of the contagious disease of HBV.

    Figure 2.  The view of computer generated pictures illustrating the dynamics of compartmental populations of the proposed problem against various initial sizes of populations and the parameters values: Π=175, τ=0.000000001, θ1=0.2, α0=0.0499567816, ν=0.02, θ2=0.01865, κ1=0.08567816, τ1=0.00204720925, κ2=0.01, ρ1=0.02, τ2=0.5532, ρ2=0.015, and τ3=0.0404720925. This investigates disease-free equilibrium stability as stated by Theorems 3.1.
    Figure 3.  The graphs visualize the dynamics of compartmental populations of the proposed problem for various initial sizes of populations and the following parameters values: Π=175, τ=0.000001, θ1=0.2, α0=0.029956, ν=0.05, θ2=0.00001865, κ1=0.0008567816, τ1=0.00010472, κ2=0.0001, ρ1=0.00002, τ2=0.0005532, ρ2=0.000015, and τ3=0.0000404720925. This investigates the stability of endemic equilibrium as stated by Theorem 3.4.

    In addition to showing the effect of the proposed control mechanism by presenting the simulation of the control analysis, we want to differentiate between the control and without control implementation. Therefore, we use the forward Runge-Kutta method of the 4th order to solve the state system (4.2), while the adjoint system (5.5) will be solved with the help of backward Runge-Kutta method of the 4th order. All the values for parameters are given in the captions of the figures representing the control implementation analysis. Thus, as a result, we obtain the graphs as represented by Figure 4, which describe the dynamics of susceptible (Figure 4(a)), acute (Figure 4(b)), chronic (Figure 4(c)), hospitalized (Figure 4(d)), and recovered (Figure 4(e)) individuals with and without control measures. The graphs clearly illustrate the effect of control strategies: to reduce the infected and to increase the recovered populations. The difference between the two cases is clearly visible. We observed that the collective implementation of the proposed control measures optimally leads to eradicating the contagious disease of HBV transmission.

    Figure 4.  These graphs represent the validity of control measure implementation to illustrate the dynamics of compartmental populations of the proposed problem with and without control, where the parametric values are chosen as: Π=175, τ=0.000000001, θ1=0.2, α0=0.0499567816, v=0.02, θ2=0.01865, κ1=0.08567816, τ1=0.00204720925, κ2=0.01, ρ1=0.02, τ2=0.5532, ρ2=0.015, and τ3=0.0404720925.

    In this work, we presented a more generalized epidemiological model for HBV transmission by including the new features according to the characteristic of the disease. The incidence parameter plays an essential role in the dynamics and control of biological models; therefore, we use the generalized saturated incidence rate β{I1+I2+I3++In}S1+γ{I1+I2+I3++In} to study the temporal dynamics of hepatitis B, which is more suitable as compared to traditional incidence rates. Because hepatitis B is a multi-infection disease, the traditional saturated incidence rate βSI1+γI is not appropriate while investigating the dynamics of HBV transmission. Thus, considering the disease's characteristics, we formulated the model and discuss the feasibility of the problem. We then calculate the disease-free equilibria and consequently the basic reproductive number R0 with the help of a well-known technique of the next-generation matrix approach. In a similar fashion, the endemic state is also derived using the reproductive number and then the detailed stability analysis is discussed via various approaches to derive the stability conditions. For this, the linearization, as well as the Lyapunov theory, are retrieved to discuss the local and global properties of the newly constructed model. In addition, very importantly, we then use three control measures and design a control mechanism with the aid of optimal control theory that, how to eliminate the infection of hepatitis B. At last, all the theoretical as well as analytical findings are supported via graphical representations with the help of numerical experiments to show the validity of the model and the effects of control implementation.

    In the future, we will consider the protection awareness to separate the susceptible individuals into two groups, i.e., susceptible with protection awareness and susceptible without protection awareness.

    The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.

    This work was supported by Research Supporting Project Number (RSP2024R421), King Saud University, Riyadh, Saudi Arabia. The work has been also supported by the UAE University, fund No. 12S107. Further, this work is supported by the University Innovation Foundation of China (Grant No. 2022IT101) and the Basic Education Quality Improvement Research Center project Foundation of Xinjiang province (Grant No. WKJDJSZD23002).

    The authors declare there is no conflict of interest.



    [1] M. H. Chang, Hepatitis B virus infection, Semin. Fetal Neonatal Med., 12 (2007), 160–167. https://doi.org/10.1017/CBO9781139012102 doi: 10.1017/CBO9781139012102
    [2] M. R. Hall, D. Ray, J. A. Payne, Prevalence of hepatitis C, hepatitis B, and human immunodeficiency virus in a grand rapids, michigan emergency department, J. Emerg. Med., 38 (2010), 401–405. https://doi.org/10.1016/j.jemermed.2008.03.036 doi: 10.1016/j.jemermed.2008.03.036
    [3] W. Edmunds, G. Medley, D. Nokes, A. Hall, H. Whittle, The influence of age on the development of the hepatitis B carrier state, Proc. R. Soc. Ser. B Biol. Sci., 253 (1993), 197–201. https://doi.org/10.1098/rspb.1993.0102 doi: 10.1098/rspb.1993.0102
    [4] J. Mann, M. Roberts, Modelling the epidemiology of hepatitis B in New Zealand, J. Theor. Biol., 269 (2011), 266–272. https://doi.org/10.1016/j.jtbi.2010.10.028 doi: 10.1016/j.jtbi.2010.10.028
    [5] M. Jakab, J. Farrington, L. Borgermans, F. Mantingh, Health Systems Respond to Noncommunicable Diseases: Time for Ambition, World Health Organization, Regional Office for Europe, 2018.
    [6] D. Lavanchy, Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures, J. Viral Hepatitis, 11 (2004), 97–107.
    [7] B. J. McMahon, Epidemiology and natural history of hepatitis B, Semin. Liver Dis., 25 (2005), 3–8. https://doi.org/10.1055/s-2005-915644 doi: 10.1055/s-2005-915644
    [8] F. Brauer, Some simple epidemic models, Math. Biosci. Eng., 3 (2006). https://doi.org/10.3934/mbe.2006.3.1 doi: 10.3934/mbe.2006.3.1
    [9] J. Wang, J. Pang, X. Liu, Modelling diseases with relapse and nonlinear incidence of infection: a multi-group epidemic model, J. Biol. Dyn., 8 (2014), 99–116. https://doi.org/10.1080/17513758.2014.912682 doi: 10.1080/17513758.2014.912682
    [10] J. Wang, R. Zhang, T. Kuniya, The stability analysis of an SVEIR model with continuous age-structure in the exposed and infectious classes, J. Biol. Dyn., 9 (2015), 73–101. https://doi.org/10.1080/17513758.2015.1006696 doi: 10.1080/17513758.2015.1006696
    [11] B. Alten, C. Maia, M. O. Afonso, L. Campino, M. Jiménez, E. González, et al., Seasonal dynamics of phlebotomine sand fly species proven vectors of mediterranean leishmaniasis caused by leishmania infantum, PLoS Negl. Trop. Dis., 10 (2016), e0004458. https://doi.org/10.1371/journal.pntd.0004458 doi: 10.1371/journal.pntd.0004458
    [12] D. Sereno, Epidemiology of vector-borne diseases 2.0, Microorganisms, 10 (2022), 1555. https://doi.org/10.3390/microorganisms10081555 doi: 10.3390/microorganisms10081555
    [13] B. Li, H. Liang, L. Shi, Q. He, Complex dynamics of Kopel model with nonsymmetric response between oligopolists, Chaos, Solitons Fractals, 156 (2022), 111860. https://doi.org/10.1016/j.chaos.2022.111860 doi: 10.1016/j.chaos.2022.111860
    [14] Q. He, M. U. Rahman, C. Xie, Information overflow between monetary policy transparency and inflation expectations using multivariate stochastic volatility models, Appl. Math. Sci. Eng., 31 (2023), 2253968. https://doi.org/10.1080/27690911.2023.2253968 doi: 10.1080/27690911.2023.2253968
    [15] B. Li, T. Zhang, C. Zhang, Investigation of financial bubble mathematical model under fractal-fractional Caputo derivative, Fractals, 31 (2023), 1–13. https://doi.org/10.1142/S0218348X23500500 doi: 10.1142/S0218348X23500500
    [16] F. Brauer, C. Castillo-Chavez, C. Castillo-Chavez, Mathematical Models in Population Biology and Epidemiology, Springer, 2 (2012).
    [17] W. O. Kermack, A. G. McKendrick, A contribution to the mathematical theory of epidemics, Proc. R. Soc. London, Ser. A, 115 (1927), 700–721. https://doi.org/10.1098/rspa.1927.0118 doi: 10.1098/rspa.1927.0118
    [18] X. Zhai, W. Li, F. Wei, X. Mao, Dynamics of an HIV/AIDS transmission model with protection awareness and fluctuations, Chaos, Solitons Fractals, 169 (2023), 113224. https://doi.org/10.1016/j.chaos.2023.113224 doi: 10.1016/j.chaos.2023.113224
    [19] J. Williams, D. Nokes, G. Medley, R. Anderson, The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunization programmes, Epidemiol. Infect., 116 (1996), 71–89. https://doi.org/10.1017/S0950268800058970 doi: 10.1017/S0950268800058970
    [20] F. A. Rihan, H. J. Alsakaji, Analysis of a stochastic hbv infection model with delayed immune response, Math. Biosci. Eng., 18 (2021), 5194–5220. https://doi.org/10.3934/mbe.2021264 doi: 10.3934/mbe.2021264
    [21] T. Xue, L. Zhang, X. Fan, Dynamic modeling and analysis of hepatitis B epidemic with general incidence, Math. Biosci. Eng., 20 (2023), 10883–10908. https://doi.org/10.3934/mbe.2023483 doi: 10.3934/mbe.2023483
    [22] G. F. Medley, N. A. Lindop, W. J. Edmunds, D. J. Nokes, Hepatitis-B virus endemicity: heterogeneity, catastrophic dynamics and control, Nat. Med., 7 (2001), 619–624. https://doi.org/10.1038/87953 doi: 10.1038/87953
    [23] S. Zhao, Z. Xu, Y. Lu, A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in China, Int. J. Epidemiol., 29 (2000), 744–752. https://doi.org/10.1093/ije/29.4.744 doi: 10.1093/ije/29.4.744
    [24] T. Khan, G. Zaman, M. I. Chohan, The transmission dynamic of different hepatitis B-infected individuals with the effect of hospitalization, J. Biol. Dyn., 12 (2018), 611–631. https://doi.org/10.1080/17513758.2018.1500649 doi: 10.1080/17513758.2018.1500649
    [25] T. Khan, Z. Ullah, N. Ali, G. Zaman, Modeling and control of the hepatitis B virus spreading using an epidemic model, Chaos, Solitons Fractals, 124 (2019), 1–9. https://doi.org/10.1016/j.chaos.2019.04.033 doi: 10.1016/j.chaos.2019.04.033
    [26] M. Fan, M. Y. Li, K. Wang, Global stability of an SEIS epidemic model with recruitment and a varying total population size, Math. Biosci., 170 (2001), 199–208. https://doi.org/10.1016/S0025-5564(00)00067-5 doi: 10.1016/S0025-5564(00)00067-5
    [27] J. Li, Z. Ma, Qualitative analyses of SIS epidemic model with vaccination and varying total population size, Math. Comput. Modell., 35 (2002), 1235–1243. https://doi.org/10.1016/S0895-7177(02)00082-1 doi: 10.1016/S0895-7177(02)00082-1
    [28] L. Zou, W. Zhang, S. Ruan, Modeling the transmission dynamics and control of hepatitis B virus in China, J. Theor. Biol., 262 (2010), 330–338. https://doi.org/10.1016/j.jtbi.2009.09.035 doi: 10.1016/j.jtbi.2009.09.035
    [29] V. Capasso, G. Serio, A generalization of the kermack-mckendrick deterministic epidemic model, Math. Biosci., 42 (1978), 43–61. https://doi.org/10.1016/0025-5564(78)90006-8 doi: 10.1016/0025-5564(78)90006-8
    [30] J. Zhang, J. Jia, X. Song, Analysis of an SEIR epidemic model with saturated incidence and saturated treatment function, Sci. World J., 2014 (2014). https://doi.org/10.1155/2014/910421 doi: 10.1155/2014/910421
    [31] T. Khan, G. Zaman, Classification of different hepatitis B infected individuals with saturated incidence rate, SpringerPlus, 5 (2016), 1–16. https://doi.org/10.1186/s40064-016-2706-3 doi: 10.1186/s40064-016-2706-3
    [32] D. Li, F. Wei, X. Mao, Stationary distribution and density function of a stochastic SVIR epidemic model, J. Franklin Inst., 359 (2022), 9422–9449. https://doi.org/10.1016/j.jfranklin.2022.09.026 doi: 10.1016/j.jfranklin.2022.09.026
    [33] O. Diekmann, J. A. P. Heesterbeek, J. A. Metz, On the definition and the computation of the basic reproduction ratio r0 in models for infectious diseases in heterogeneous populations, J. Math. Biol., 28 (1990), 365–382. https://doi.org/10.1007/BF00178324 doi: 10.1007/BF00178324
    [34] P. Van den Driessche, J. Watmough, Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission, Math. Biosci., 180 (2002), 29–48. https://doi.org/10.1016/S0025-5564(02)00108-6 doi: 10.1016/S0025-5564(02)00108-6
    [35] A. V. Kamyad, R. Akbari, A. A. Heydari, A. Heydari, Mathematical modeling of transmission dynamics and optimal control of vaccination and treatment for hepatitis B virus, Comput. Math. Methods Med., 2014 (2014). https://doi.org/10.1155/2014/475451 doi: 10.1155/2014/475451
    [36] G. Zaman, Y. H. Kang, I. H. Jung, Stability analysis and optimal vaccination of an SIR epidemic model, BioSystems, 93 (2008), 240–249. https://doi.org/10.1016/j.biosystems.2008.05.004 doi: 10.1016/j.biosystems.2008.05.004
  • Reader Comments
  • © 2024 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(1498) PDF downloads(142) Cited by(0)

Figures and Tables

Figures(4)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog